Tortoise Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Sell |
24
-50
| -68% | -$26.3K | ﹤0.01% | 568 |
|
|
2025
Q1 | $46.9K | Sell |
74
-77
| -51% | -$48.8K | ﹤0.01% | 382 |
|
|
2024
Q4 | $108K | Buy |
151
+1
| +0.7% | +$712 | 0.01% | 298 |
|
|
2024
Q3 | $158K | Hold |
150
| – | – | 0.02% | 255 |
|
|
2024
Q2 | $158K | Hold |
150
| – | – | 0.02% | 249 |
|
|
2024
Q1 | $144K | Hold |
150
| – | – | 0.02% | 253 |
|
|
2023
Q4 | $132K | Hold |
150
| – | – | 0.02% | 248 |
|
|
2023
Q3 | $123K | Sell |
150
-25
| -14% | -$20.6K | 0.02% | 249 |
|
|
2023
Q2 | $126K | Hold |
175
| – | – | 0.02% | 254 |
|
|
2023
Q1 | $144K | Hold |
175
| – | – | 0.02% | 221 |
|
|
2022
Q4 | $126K | Hold |
175
| – | – | 0.02% | 234 |
|
|
2022
Q3 | $121K | Hold |
175
| – | – | 0.02% | 228 |
|
|
2022
Q2 | $103K | Buy |
175
+55
| +46% | +$32.4K | 0.02% | 224 |
|
|
2022
Q1 | $84K | Hold |
120
| – | – | 0.02% | 243 |
|
|
2021
Q4 | $76K | Hold |
120
| – | – | 0.01% | 243 |
|
|
2021
Q3 | $73K | Buy |
120
+100
| +500% | +$60.8K | 0.01% | 234 |
|
|
2021
Q2 | $11K | Hold |
20
| – | – | ﹤0.01% | 456 |
|
|
2021
Q1 | $9K | Hold |
20
| – | – | ﹤0.01% | 452 |
|
|
2020
Q4 | $10K | Hold |
20
| – | – | ﹤0.01% | 416 |
|
|
2020
Q3 | $11K | Hold |
20
| – | – | ﹤0.01% | 370 |
|
|
2020
Q2 | $12K | Hold |
20
| – | – | ﹤0.01% | 347 |
|
|
2020
Q1 | $10K | Buy |
+20
| New | +$10K | ﹤0.01% | 364 |
|
|
2019
Q2 | – | Sell |
-12
| Closed | -$5K | – | 643 |
|
|
2019
Q1 | $5K | Buy |
+12
| New | +$5K | ﹤0.01% | 482 |
|
|
2017
Q2 | – | Sell |
-11
| Closed | -$4K | – | 509 |
|
|
2017
Q1 | $4K | Buy |
+11
| New | +$4K | ﹤0.01% | 405 |
|